Results
Revise Search
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada
https://policybase.cma.ca/en/permalink/policy13936
- Date
- 2016-10-18
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Health care and patient safety
1 document
- Policy Type
- Parliamentary submission
- Date
- 2016-10-18
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Health care and patient safety
Documents
Consultation on the prescription drug list: Naloxone
https://policybase.cma.ca/en/permalink/policy11847
- Date
- 2016-03-17
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Association. Policy Document PD15-06 - Harms associated with opioids and other
psychoactive prescriptions
1 document
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health
https://policybase.cma.ca/en/permalink/policy11035
- Date
- 2013-11-27
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
